First assessment of classical swine fever marker vaccine candidate CP7_E2alf for oral immunization of wild boar under field conditions (Q39245465)

10 September 2017

title

First assessment of classical swine fever marker vaccine candidate CP7_E2alf for oral immunization of wild boar under field conditions (English)

1 reference

10 September 2017

0 references

0 references

classical swine fever

1 reference

Martin Beer

1 reference

10 September 2017

Sandra Blome

1 reference

10 September 2017

Francesco Feliziani

1 reference

10 September 2017

Stefano Petrini

1 reference

10 September 2017

Monica Giammarioli

1 reference

10 September 2017

Carmen Iscaro

1 reference

10 September 2017

Giulio Severi

1 reference

10 September 2017

Luca Convito

1 reference

10 September 2017

Jana Pietschmann

1 reference

10 September 2017

Gian Mario De Mia

1 reference

10 September 2017

language of work or name

English

0 references

publication date

22 February 2014

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

2050-2055

1 reference

Molecular epidemiology of classical swine fever in Italy

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Epidemiology of classical swine fever in Germany in the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Incidence and control of CSF in wild boar in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Epidemiology of classical swine fever in Sardinia: a serological survey of wild boar and comparison with African swine fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Molecular tracing of classical swine fever viruses isolated from wild boars and pigs in France from 2002 to 2011.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Incidence and persistence of classical swine fever in free-ranging wild boar (Sus scrofa).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Prevalence of antibodies to classical swine fever, Aujeszky's disease, porcine reproductive and respiratory syndrome, and bovine viral diarrhoea viruses in wild boars in Croatia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Retrospective analysis of the oral immunisation of wild boar populations against classical swine fever virus (CSFV) in region Eifel of Rhineland-Palatinate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Genetic differentiation of infected from vaccinated animals after implementation of an emergency vaccination strategy against classical swine fever in wild boar

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Preventive vaccination contributes to control classical swine fever in wild boar (Sus scrofa sp.).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Novel marker vaccines against classical swine fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Iophenoxic acid derivatives as markers of oral baits to wildlife. New tools for their detection in tissues of a game species and safety considerations for human exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Genetic typing of classical swine fever virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.006

10.1016/J.VACCINE.2014.02.006

7 January 2021

Identifiers

DOI

1 reference

10 September 2017

1 reference